Clinical trialNo phase (not a drug trial)Unknown
Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT
Usefulness of Low kVp High mAs Computed Tomography for the Evaluation of Pancreatic Cancer Resectability
- Outcome
- Outcome unknown
- Phase
- No phase (not a drug trial)
- Status
- Unknown
- Study type
- Interventional
- Start
- 12 March 2019
- Listed end
- 31 January 2022
- Enrollment
- 147 participants
- Sites
- 6
- Primary outcomes
- accuracy of low kVp CT to assess R0 resection of pancreatic cancer
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 22 March 2021
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The aim of this study is to investigate usefulness of low kVp high mAs computed tomography in evaluation of pancreatic cancer resectability.